A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease

NCT07428096 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibrostenotic Crohn's Disease

Interventions

DRUG: PALI-2108

Sponsor

Palisade Bio

Collaborators

Altasciences Company Inc.